Effects of the “AI-TA” Mobile App With Intelligent Design on Psychological and Related Symptoms of Young Survivors of Breast Cancer: Randomized Controlled Trial (Preprint)
Authors: Jiang Lulu , Xu Jiehui , Wu Yanwei , Liu Yanyan , Wang Xiyi , Hu Yun 
Published: July 2023

BACKGROUND

Young women often face substantial psychological challenges in the initial years following cancer diagnosis, leading to a comparatively lower quality of life than older survivors. While mobile apps have emerged as potential interventions, their effectiveness remains inconclusive due to the diversity in intervention types and variation in follow-up periods. Furthermore, there is a particular dearth of evidence regarding the efficacy of these apps’ intelligent features in addressing psychological distress with these apps.

OBJECTIVE

This study aims to evaluate the effectiveness of a mobile app with intelligent design called “<i>AI-TA</i>” on cancer-related psychological health and ongoing symptoms with a randomized controlled design.

METHODS

Women aged 18 to 45 years diagnosed with breast cancer were randomly assigned to the intervention or control group. The intervention was <i>AI-TA</i>, which included 2-way web-based follow-up every 2 weeks. Both intention-to-treat (ITT) and per-protocol (PP) analyses employed repeated measurement analysis of variance. The participants’ background features, primary outcomes (psychological distress and frequency, self-efficacy, and social support), and secondary outcomes (quality of life) were measured using multiple instruments at 3 time points (baseline, 1-month intervention, and 3-month intervention).

RESULTS

A total of 124 participants were randomly allocated to the control group (n=62, 50%) or intervention group (n=62, 50%). In total, 92.7% (115/124) of the participants completed the intervention. Significant improvements in psychological symptoms (Memorial Symptom Assessment Scale-Short Form) were observed in the ITT group from baseline to 1-month intervention relative to the control group (ITT vs control: 1.17 vs 1.23; <i>P</i>&lt;.001), which persisted at 3-month follow-up (ITT vs control: 0.68 vs 0.91; <i>P</i>&lt;.001). Both the ITT and PP groups exhibited greater improvements in self-efficacy (Cancer Behavior Inventory-Brief Version) than the control group at 1-month (ITT vs PP vs control: 82.83 vs 77.12 vs 65.35; <i>P</i>&lt;.001) and 3-month intervention (ITT vs PP vs control: 92.83 vs 89.30 vs 85.65; <i>P</i>&lt;.001). However, the change in social support (Social Support Rating Scale) did not increase significantly until 3-month intervention (ITT vs control: 50.09 vs 45.10; <i>P</i>=.002) (PP vs control: 49.78 vs 45.10; <i>P</i>&lt;.001). All groups also experienced beneficial effects on quality of life (Functional Assessment of Cancer Therapy-Breast), which persisted at 3-month follow-up (<i>P</i>&lt;.001).

CONCLUSIONS

The intelligent mobile app <i>AI-TA</i> incorporating intelligent design shows promise for reducing psychological and cancer-related symptoms among young survivors of breast cancer.

CLINICALTRIAL

Chinese Clinical Trial Registry ChiCTR2200058823; https://www.chictr.org.cn/showproj.html?proj=151195